[go: up one dir, main page]

AU693982B2 - Genes and gene products for use in the diagnosis of degenerative nerve damage - Google Patents

Genes and gene products for use in the diagnosis of degenerative nerve damage

Info

Publication number
AU693982B2
AU693982B2 AU43023/96A AU4302396A AU693982B2 AU 693982 B2 AU693982 B2 AU 693982B2 AU 43023/96 A AU43023/96 A AU 43023/96A AU 4302396 A AU4302396 A AU 4302396A AU 693982 B2 AU693982 B2 AU 693982B2
Authority
AU
Australia
Prior art keywords
genes
diagnosis
gene products
nerve damage
degenerative nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43023/96A
Other languages
English (en)
Other versions
AU4302396A (en
Inventor
Clemens Gillen
Marc Gleichmann
Hans-Werner Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19502525A external-priority patent/DE19502525A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU4302396A publication Critical patent/AU4302396A/en
Application granted granted Critical
Publication of AU693982B2 publication Critical patent/AU693982B2/en
Priority to AU87871/98A priority Critical patent/AU8787198A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU43023/96A 1994-12-05 1995-12-05 Genes and gene products for use in the diagnosis of degenerative nerve damage Ceased AU693982B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU87871/98A AU8787198A (en) 1994-12-05 1998-10-02 Genes and gene products for use in the diagnosis of degenerative nerve damage

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4443159 1994-12-05
DE4443159 1994-12-05
DE9502525 1995-01-27
DE19502525A DE19502525A1 (de) 1994-12-05 1995-01-27 Neue Gene und Genprodukte zur Diagnostik und Regeneration degenerativer Nervenschädigungen
PCT/EP1995/004777 WO1996017865A2 (de) 1994-12-05 1995-12-05 Gene und genprodukte zur diagnostik von degenerativer nervenschädigung

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU87871/98A Division AU8787198A (en) 1994-12-05 1998-10-02 Genes and gene products for use in the diagnosis of degenerative nerve damage

Publications (2)

Publication Number Publication Date
AU4302396A AU4302396A (en) 1996-06-26
AU693982B2 true AU693982B2 (en) 1998-07-09

Family

ID=25942564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43023/96A Ceased AU693982B2 (en) 1994-12-05 1995-12-05 Genes and gene products for use in the diagnosis of degenerative nerve damage

Country Status (5)

Country Link
EP (1) EP0796275A2 (de)
JP (1) JPH10511544A (de)
AU (1) AU693982B2 (de)
CA (1) CA2206994A1 (de)
WO (1) WO1996017865A2 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003569A1 (en) * 1989-08-30 1991-03-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
WO1992020797A1 (en) * 1991-05-20 1992-11-26 Case Western Reserve University Neurotrophic factor, preparation and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968817A (en) * 1993-03-15 1999-10-19 The Scripps Research Institute DNA encoding serotonin receptors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003569A1 (en) * 1989-08-30 1991-03-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
WO1992020797A1 (en) * 1991-05-20 1992-11-26 Case Western Reserve University Neurotrophic factor, preparation and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
INT IMMUNOL 2:585 (1990) *
J BIOL CHEM 269:24912 (1990) *

Also Published As

Publication number Publication date
WO1996017865A2 (de) 1996-06-13
JPH10511544A (ja) 1998-11-10
AU4302396A (en) 1996-06-26
EP0796275A2 (de) 1997-09-24
WO1996017865A3 (de) 1996-09-19
CA2206994A1 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
AU2095599A (en) Human genes and gene expression products i
AU4187499A (en) Human genes and gene expression products v
AU2543795A (en) Methods of in vivo gene delivery
AU4053699A (en) Novel human genes and gene expression products
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU3119495A (en) Surgical product and its use
IL126418A0 (en) Hormone-mediated methods for modulating expression of exogenous genes and pharmaceutical compositions for modulating the same
IL105914A0 (en) Methods and compositions for in vivo gene therapy
AU2103097A (en) Cinnoline derivatives and use as medicine
AU5769994A (en) Electrosurgery monitor and apparatus
AU1603199A (en) Methods and devices for measuring differential gene expression
AU4172597A (en) Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
AU1642395A (en) Alpha-aminoalkanoic acids and reduction products
AU7180298A (en) Nucleic acid encoding schwannominbinding-proteins and products related th ereto
AU2861695A (en) Mn gene and protein
AU9565598A (en) Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis
AU6819194A (en) Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
AU8536998A (en) Regulatory sequences involved in hypoxia regulated gene expression and uses thereof
AU2687397A (en) Method and reagents for testing for mutations in the brca1 gene
AU6950096A (en) Methods and compositions for nucleic acid targeting
AU7265298A (en) Methods and compositions for targeted dna differential display
AU3698297A (en) Compositions containing at least one nucleic acid and their applications in the biomedical field, particularly in gene therapy
AU4904097A (en) Gene delivery and expression in areas inaccessible to direct protein delivery
AU6331996A (en) The erf genetic locus and its products
AU1187597A (en) Compositions and methods for diagnosis of mutation in the von hippel-lindau tumor suppressor gene

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired